These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20973717)

  • 21. Use of valproate in women of childbearing potential: pre- and post-NICE bipolar guidelines.
    Vasudev K; Mead A
    Arch Womens Ment Health; 2010 Aug; 13(4):371-2. PubMed ID: 20440523
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum Valproic Acid Levels During Initial Conversion of Antituberculoid Therapy in Bipolar Mania: A Case Report and Literature Review.
    DeLucia B; Mahon J
    Psychosomatics; 2017; 58(4):446-449. PubMed ID: 28413090
    [No Abstract]   [Full Text] [Related]  

  • 23. Manic switch and serotonin syndrome with venlafaxine-lithium-valproate association.
    Liberek C; Aubry JM; Baud P
    Therapie; 2006; 61(6):531-3. PubMed ID: 17348610
    [No Abstract]   [Full Text] [Related]  

  • 24. Valproate-induced hyperammonemic encephalopathy: a case report.
    Shah S; Wang R; Vieux U
    J Med Case Rep; 2020 Jan; 14(1):19. PubMed ID: 31980035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valproate (VPA)-associated hyperammonemic encephalopathy independent of elevated serum VPA levels: 21 cases in China from May 2000 to May 2012.
    Cheng M; Tang X; Wen S; Yue J; Wang H
    Compr Psychiatry; 2013 Jul; 54(5):562-7. PubMed ID: 23246073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Caution and warning: About valproate and pregnancy].
    Masson M; Huberfeld G; Richa S; Henry C; Gaillard R
    Encephale; 2016 Oct; 42(5):391-394. PubMed ID: 27842894
    [No Abstract]   [Full Text] [Related]  

  • 27. Potential risks associated with high-dose valproate in pregnancy in psychiatric patients.
    Vajda FJ; Solinas C
    Aust N Z J Psychiatry; 2005 Jun; 39(6):526-7. PubMed ID: 15943661
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of valproate-induced hyperammonemia.
    Stewart JT
    J Am Geriatr Soc; 2005 Jun; 53(6):1080. PubMed ID: 15935047
    [No Abstract]   [Full Text] [Related]  

  • 29. A case of valproate-induced encephalopathy.
    Hong L; Schutz J; Nance M
    Aust N Z J Psychiatry; 2012 Dec; 46(12):1200-1. PubMed ID: 22619383
    [No Abstract]   [Full Text] [Related]  

  • 30. Reversible taste and smell dysfunction associated with sodium valproate and quetiapine in bipolar depression: a case report.
    Alvarez P; Papaseit E; Pérez V; Bulbena A; Farré M
    Actas Esp Psiquiatr; 2019 Jan; 47(1):33-6. PubMed ID: 30724329
    [No Abstract]   [Full Text] [Related]  

  • 31. Valproate-induced hyperammonemia in mental retardation: a case report and review of the literature.
    Khoo CL; Naik S; Lua R; Chai SB; Liew A; Sim K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):561-2. PubMed ID: 20184937
    [No Abstract]   [Full Text] [Related]  

  • 32. The valproate serum level in maintenance therapy for bipolar disorder in Japan.
    Machino A; Jitsuiki H; Okamoto Y; Izumitani S; Kimura Y; Suzuki K; Tanaka T; Inoue T; Koyama T; Wada K; Masaoka Y; Sasaki T; Yoshimura R; Nakamura J; Sumitan S; Ohmori T; Yamawaki S
    Hiroshima J Med Sci; 2013 Mar; 62(1):7-12. PubMed ID: 23600328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Valproate-induced encephalopathy related to concurrent antimanic medications.
    Trojak B; de la Gastine B; Dollfus S
    J Neuropsychiatry Clin Neurosci; 2011; 23(1):E22-3. PubMed ID: 21304120
    [No Abstract]   [Full Text] [Related]  

  • 34. Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting.
    Dealberto MJ
    Int Clin Psychopharmacol; 2007 Nov; 22(6):330-7. PubMed ID: 17917551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid development of severe skin rash after adding valproic acid in a case of bipolar depression treated with low-dose lamotrigine.
    Chou YC; Chao FH; Chou YH
    J Formos Med Assoc; 2014 Mar; 113(3):195-6. PubMed ID: 24630038
    [No Abstract]   [Full Text] [Related]  

  • 36. [Valproate-induced hyperammonemic encephalopathy in a neonate: treatment with carglumic acid].
    Fernández Colomer B; Rekarte García S; García López JE; Pérez González C; Montes Granda M; Coto Cotallo GD
    An Pediatr (Barc); 2014 Oct; 81(4):251-5. PubMed ID: 24315420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valproate and polycystic ovaries.
    Irwin M; Masand P
    J Am Acad Child Adolesc Psychiatry; 1998 Jan; 37(1):9-10. PubMed ID: 9444888
    [No Abstract]   [Full Text] [Related]  

  • 38. Neutropenia associated with the comedication of quetiapine and valproate in 2 elderly patients.
    Hung WC; Hsieh MH
    J Clin Psychopharmacol; 2012 Jun; 32(3):416-7. PubMed ID: 22561472
    [No Abstract]   [Full Text] [Related]  

  • 39. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
    Nasrallah HA; Ketter TA; Kalali AH
    J Affect Disord; 2006 Oct; 95(1-3):69-78. PubMed ID: 16780960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effectiveness of high-dosage amisulpride combined with moderate-dosage sodium valproate treatment for an overweight patient with psychotic bipolar disorder.
    Hou YC; Lai CH
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E34-5. PubMed ID: 24763785
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.